Health and Healthcare

All Health and Healthcare Articles

Newest first · Page 382

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology BIONOVO INC +27.33% $0 CORCEPT THERAPEUTICS +20.19% $99.2 M OPEXA THERAPEUTICS +11.11% $0 PANACOS PHARMA INC +8.29% $49.9 M AURIGA LABORATORIES +7.14% Diagnostic Substances ICAGEN, INC. +20.93% AVALON PHARMACEUTIC +6.71%…

Douglas A. McIntyre · 20 years ago

Merck Pressured to Halt Gardasil Vaccine Lobbying

By H.S. AyoubBioHealth Investor.com I wrote earlier about the anti-vaccination movement, and how Merck (MRK) has been receiving a lot of backlash because of its lobbying efforts. Merck (MRK) has been lobbying pretty hard…

Douglas A. McIntyre · 20 years ago

Pharmacyclics: A Biotech Meltdown

Pharmacyclics, Inc. (PCYC-NASDAQ) is trading down over 40% pre-market after receiving a ‘refuse to file’ letter from the FDA for its new drug application for Xcytrin® Injection for the treatment of non-small cell lung…

Douglas A. McIntyre · 20 years ago

Tuesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INSMED INC +29.66% BIODELIVERY SCI INTL +26.90% CYTRX CP +15.85% BIONOVO INC +15.83% AURIGA LABORATORIES +10.89% Diagnostic Substances ICAGEN, INC. +22.86% THRESHOLD PHARMACEUT +9.25% AVIGEN INC +8.36% PRESSURE BIOSCIENC +6.23%…

Douglas A. McIntyre · 20 years ago

Novadel Drops After Zensana Launch Delayed by Hana Biosciences

by H.S. AyoubBioHealth Investor.com Shares of Novadel (NVD), a BHI Stock Pick, lost 13% in after hours trading on Tuesday following an announcement by Hana Biosciences (HNAB) that the launch of Zensana will be…

Douglas A. McIntyre · 20 years ago

Osiris: Promising Stem Cell Research, Questionable Management

by H.S. AyoubBioHealth Investor.com While investors must research the history of any company’s management and executives, it is even more imperative in the biotech industry. Cutting edge medical research is both risky and expensive,…

Douglas A. McIntyre · 20 years ago

Friday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology INSMED INC +16.83% ONYX PHARM INC +12.35% ACORDA THERAPEUTICS +8.54% ORTHOLOGIC CP +8.50% LEV PHARMACEUTICALS +7.36% Diagnostic Substances NYMOX PHARM CORP +9.41% REMOTEMDX INC +8.47% COLEY PHARMACEUTICAL +6.59% IMMUNOMEDICS INC…

Douglas A. McIntyre · 20 years ago

Thursday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology DYAX CORP +14.61% CYTRX CP +14.00% FERMAVIR PHARMACEUTL +8.82% LIFECORE BIOMEDICA +6.51% BIOMIRA INC +6.25% Diagnostic Substances ICAGEN, INC. +5.33% TRINITY BIO ADR +4.43% SYNOVICS PHARMACEUTL +3.70% GENE LOGIC INC…

Douglas A. McIntyre · 20 years ago

IPO Filing: NovaBay Pharmaceuticals

NovaBay Pharmaceuticals has filed to come public via an IPO, although this one is being put on the American Stock Exchange instead of NASDAQ or NYSE.  It will also trade in Canada on the…

Douglas A. McIntyre · 20 years ago

Wednesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology SGX PHARMACEUTICALS +25.78% HALOZYME THERAPEUTIC +11.59% FAVRILLE, INC. +10.41% INVITROGEN CORP +9.92% ARIAD PHARM INC +6.36% Diagnostic Substances ABAXIS INC +6.84% PRESSURE BIOSCIENC +5.27% AMER BIO MEDICA +4.76% IMMUNOMEDICS INC…

Douglas A. McIntyre · 20 years ago

Tuesday’s Top Biotech and Medical Stocks

From BioHealth Investor Biotechnology ONYX PHARM INC +7.74% REGENERON PHARMACE +6.86% DYAX CORP +6.85% PROGEN INDS LTD +6.78% ILLUMINA INC +6.47% Diagnostic Substances AMER BIO MEDICA +8.62% AVALON PHARMACEUTIC +7.94% IMMUNOMEDICS INC +6.51% MONOGRAM…

Douglas A. McIntyre · 20 years ago

Are NovaDel and Pfizer Collaborating on a Viagra Spray?

by H.S. AyoubBioHealth Investor.com The Business, a British business magazine, published an article early January on rumors that Pfizer (PFE) may have contacted NovaDel Pharma (NVD) to initiate research into the development of a…

Douglas A. McIntyre · 20 years ago

Illumina’s Double Play (Revise)

Shares in Illumina (ILMN), a company that makes chips and tools for testing genetic variations, are up 5% to $36.70 on 14 million shares. The company made two announcements. One is that it will…

Douglas A. McIntyre · 20 years ago